PSMA I&T - GMP
Application
Targeting of the prostate-specific membrane antigen for imaging & therapy. Enantiomerically pure, chemical precursor for radiopharmaceutical preparations with [ Ga-68], [Lu-177] or [Ac-225].
General Information
| Product no.: | 50009, 50107 |
| Product name: | PSMA I&T (TFA salt) |
| Synonyms: | (R)-DOTAGA-(I-y)fk(Sub-KuE) |
| Sequence: | Suber-1-oyl-ε-(DOTA-GA-3-iodo-D-Tyr-D-Phe-D-Lys-OH)-8-oyl-ε-(HO-Glu-CO-Lys-OH) |
| Molecular weight: | 1497.5 [g/mol] (m.i.), 1498.4 [g/mol] (av.) |
| Molecular formula: | C63H92IN11O23 |
| CAS no.: | 2647371-60-4 |
Quantity
Product No. 50009: 250 µg net peptide (lyophilisate, TFA salt)
Product No. 50107: 1000 µg net peptide (lyophilisate, TFA salt)
Clear tubular glass vials type I (borosilicate, 2 mL) with lyophilisation stoppers and closed with aluminium caps.
Storage at -20°C (± 5°C) and protected from light. A temperature increase up to +25ºC (± 2ºC) over a period of 10 days and to +40ºC (± 2ºC) over a period of 3 days does not significantly affect the purity of the chemical precursor.
- Certificate of Analysis
- Certificate of Compliance
- TSE/BSE Statement on request
Manufactured in full compliance with current GMP requirements. Specifications according to Pharm. Eur. 2902 “Chemical precursors for radiopharmaceutical preparations”.
Contact Radnostix
Use the link below to contact us or call 1.208.524.5300